Topiramate
Product Images NDC 42549-619

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 42549-619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image 100 mg (Topiramate 100 mg Label 42549)

Topiramate 100 mg tablet bottle label from STAT Rx USA LLC. The label indicates a supply of 60 tablets. It includes the NDC number 42549-621-60 and details such as manufacturer, distributor, expiration and lot numbers. The label also displays a warning to keep the medication out of the reach of children.*

FDA Label Image

Label Image 25 mg (Topiramate 25 mg Label 42549)

TOPIRAMATE 25 mg tablet label showing package contents of 60 tablets. Label indicates product is packaged and distributed by STAT Rx USA LLC in Gainesville, GA. Each tablet contains 25 mg of topiramate USP. The label also lists Caraco Pharm. Labs., Ltd. as the manufacturer in Detroit, MI. Warnings include text about drowsiness or dizziness and a notice to keep out of reach of children.*

FDA Label Image

Label Image 50 mg (Topiramate 50 mg Label 42549)

Topiramate 50 mg tablet bottle label from STAT Rx USA LLC, packaged and distributed by STAT Rx USA in Gainesville, GA. The label indicates 60 tablets per container, with NDC 42549-620-60. It states the product is generic Topiramate USP. Distributor is Caraco Pharm. Labs., Detroit, MI. The label includes a lot number, manufacturing date, and discard after date. Prescription only, keep out of reach of children.*

FDA Label Image

Topiramate-structure (Topiramate 1)

Chemical structure diagram of Topiramate, showing its molecular configuration with multiple oxygen atoms and sulfonamide group arranged in a cyclic framework.*

FDA Label Image

Topiramate-fig01 (Topiramate 2)

A line graph showing cumulative rates of time to first seizure over 500 days for two dosage groups of Topiramate: 50 mg/day and 400 mg/day. The graph compares the seizure rates, illustrating a lower cumulative rate for the 400 mg/day group. A p-value indicating statistical significance is displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.